跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,110 条关于
“JAK2/STAT5”
全部
2,110
临床试验
1,513
药物
150
机构
125
资讯
322
去年
Pegmolesatide Shows Promise as Long-Acting Anemia Treatment in Phase II Trials for CKD Patients
9个月前
Atavistik Bio Unveils Novel JAK2 V617F Mutant-Selective Inhibitors for Myeloproliferative Neoplasms at ASH 2025
去年
Vanda Pharmaceuticals' VGT-1849A, a Selective JAK2 Inhibitor, Receives FDA Orphan Drug Designation for Polycythemia Vera
上个月
Progranulin and JAK2/STAT3 Synergy Identified as Potential Target to Overcome Differentiation Block in Leukemia
4个月前
Eli Lilly Acquires Ajax Therapeutics for $2.3 Billion to Advance Novel JAK2 Inhibitor for Blood Cancers
去年
Vanda Pharmaceuticals Receives FDA Orphan Drug Designation for Novel JAK2-Selective Antisense Therapy VGT-1849B in Polycythemia Vera
24天前
Combination of JAK2 and PARP Inhibitors Shows Early Promise in Phase 1 Trial for Myelofibrosis
去年
Phase 1 Trial of Type II JAK2 Inhibitor AJ1-11095 Underway for Myelofibrosis
去年
Ajax Therapeutics and Schrödinger Expand JAK Inhibitor Partnership with New Target
10个月前
STAT Inhibitor Pipeline Expands with 22 Drugs Across 18 Companies Targeting Cancer and Inflammatory Diseases
第 1 页,共 33 页
上一页
下一页